Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Hodgkin Disease × Blood Specimen Collection × Clear all

Phase

Status

Recruiting 4 Completed 3 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 11 Carcinoma, Non-Small-Cell Lung 6 Breast Neoplasms 5 Prostatic Neoplasms 4 Neoplasm Metastasis 3 Melanoma 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Pancreatic Neoplasms 2 Neoplastic Cells, Circulating 2 Multiple Myeloma 2 Glioblastoma 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Vascular Malformations 1 Uterine Cervical Neoplasms 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Renal Insufficiency, Chronic 1 Recurrence 1 Ovarian Neoplasms 1 Ovarian Cysts 1 Osteosarcoma 1 Obesity 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma 1 Lung Neoplasms 1

Interventions

Cyclophosphamide 24 Mycophenolic Acid 15 fludarabine phosphate 13 Whole-Body Irradiation 13 fludarabine 12 Tacrolimus 11 Melphalan 11 Cyclosporine 11 Busulfan 11 Rituximab 10 Radiotherapy 10 Peripheral Blood Stem Cell Transplantation 10 Filgrastim 10 Antilymphocyte Serum 10 Doxorubicin 9 Methotrexate 8 Etoposide 8 Sirolimus 7 Gemcitabine 7 Vinblastine 6 Nivolumab 6 Methylprednisolone 6 Brentuximab Vedotin 6 pembrolizumab 5 Granulocyte Colony-Stimulating Factor 5 Dacarbazine 5 Cytarabine 5 Cord Blood Stem Cell Transplantation 5 Carmustine 5 Bleomycin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04621604 2023-10-31

REVOLUMHOD

Rennes University Hospital

Phase NA Terminated

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡